COVID-19 testing and case data is the critical piece to understanding, measuring the virus impact and guiding clinical and government decisions. Stay updated on confirmed cases and death totals, the spread of coronavirus, and the hot spots and places most impacted by this pandemic.
The growing COVID-19 pandemic is driving pharmaceutical R&D to develop therapeutics and vaccines to prevent further novel coronavirus spread.
The Global Pandemic Coalition brings together major life science, data analytics, CRO and healthcare companies to build a research database and central hub of the latest COVID-19 data. Researchers tap into the COVID-19 database through our analytics platform, that enables large-scale studies while protecting patient privacy.
Research initiatives include evaluations of drug effectiveness utilizing de-identified EHR and claims data, identifying which demographics and comorbidities correlate with higher infection rates, ventilator support or excess mortality, and measuring the public health impact of quarantine measures put in place in different geographies.
The Coalition includes Healthcare Systems, Hospitals, Labs, Clinics, Telemedicine, AI, HealthTech and many other types other healthcare providers, services and companies from 6 continents helping the fight against COVID-19 and infectious disease.
See the companies making an impact in the Global Pandemic Coalition
Antibody testing to understand global and community herd immunity.
Community antibody testing is a key step to understanding herd immunity, population risk stratification and inform community and business decisions. Current COVID-19 data primarily reflects positive/negative molecular PCR tests at that moment. IgM/IgG testing identifies antibodies developed from SARS-CoV-2 infections in symptomatic or asymptomatic recovered patients.
Reporting visibility, to both PCR and antibody tests, is critical to stay ahead of the infection curve. Our QR code platform allows immediate results uploading for our global antibody testing initiative. This program will allow better visibility to comorbidities, reinfection rates and herd immunity.
Load our free CoVSafe QR testing database for research to stop the spread of COVID-19.
Contact us to enroll your testing in the free program!